Traton SE TRATF · OTC
$37.75 +0.00% (+$0.00)
Summary
47 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has been profitable 5 years in a row.
What to watch
- Repaying its net debt would take 4.2 years of operating profit.
- Revenue growth is slowing: 3.0% a year over the last 3 years against 14% over 5 years.
- It reports a profit, yet spends more cash than it brings in.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 9.5 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 3.0% a year. For the next fiscal year analysts expect revenue to grow by 6.8%. Earnings per share grew by 11% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 EUR of revenue goes
- Cost of sales 80 EUR
- Research and development 6.6 EUR
- Sales and administration 8.0 EUR
- Taxes and other 1.5 EUR
- Net profit 4.0 EUR
Net profit, industry median (Agricultural - Machinery) 6.9 EUR
Out of every 100 EUR of revenue, 4.0 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 2.83%
- Paid out of profit
- 27%
- Raised in a row
- 4 years
You receive $1.07 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.